These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 29886325)

  • 1. Synthesis, biological evaluation and molecular modeling of novel azaspiro dihydrotriazines as influenza virus inhibitors targeting the host factor dihydrofolate reductase (DHFR).
    Francesconi V; Giovannini L; Santucci M; Cichero E; Costi MP; Naesens L; Giordanetto F; Tonelli M
    Eur J Med Chem; 2018 Jul; 155():229-243. PubMed ID: 29886325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host dihydrofolate reductase (DHFR)-directed cycloguanil analogues endowed with activity against influenza virus and respiratory syncytial virus.
    Tonelli M; Naesens L; Gazzarrini S; Santucci M; Cichero E; Tasso B; Moroni A; Costi MP; Loddo R
    Eur J Med Chem; 2017 Jul; 135():467-478. PubMed ID: 28477572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity.
    Ng HL; Chen S; Chew EH; Chui WK
    Eur J Med Chem; 2016 Jun; 115():63-74. PubMed ID: 26994844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives as potent and selective influenza virus fusion inhibitors.
    Göktaş F; Özbil M; Cesur N; Vanderlinden E; Naesens L; Cesur Z
    Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900028. PubMed ID: 31531897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microwave assisted synthesis and anti-influenza virus activity of 1-adamantyl substituted N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives.
    Göktaş F; Vanderlinden E; Naesens L; Cesur N; Cesur Z
    Bioorg Med Chem; 2012 Dec; 20(24):7155-9. PubMed ID: 23117173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifolate and antiproliferative activity of 6,8,10-triazaspiro[4.5]deca-6,8-dienes and 1,3,5-triazaspiro[5.5]undeca-1,3-dienes.
    Ma X; Chui WK
    Bioorg Med Chem; 2010 Jan; 18(2):737-43. PubMed ID: 20036565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand binding studies, preliminary structure-activity relationship and detailed mechanistic characterization of 1-phenyl-6,6-dimethyl-1,3,5-triazine-2,4-diamine derivatives as inhibitors of Escherichia coli dihydrofolate reductase.
    Srinivasan B; Tonddast-Navaei S; Skolnick J
    Eur J Med Chem; 2015 Oct; 103():600-14. PubMed ID: 26414808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and anti-coronavirus activity of a series of 1-thia-4-azaspiro[4.5]decan-3-one derivatives.
    Apaydın ÇB; Cesur N; Stevaert A; Naesens L; Cesur Z
    Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800330. PubMed ID: 31073993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a lead inhibitor for the A16V+S108T mutant of dihydrofolate reductase from the cycloguanil-resistant strain (T9/94) of Plasmodium falciparum.
    Yuthavong Y; Vilaivan T; Chareonsethakul N; Kamchonwongpaisan S; Sirawaraporn W; Quarrell R; Lowe G
    J Med Chem; 2000 Jul; 43(14):2738-44. PubMed ID: 10893311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, docking studies and biological evaluation of novel dihydro-1,3,5-triazines as human DHFR inhibitors.
    Zhou X; Lin K; Ma X; Chui WK; Zhou W
    Eur J Med Chem; 2017 Jan; 125():1279-1288. PubMed ID: 27886545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and anti-influenza virus activity of furan-substituted spirothiazolidinones.
    Apaydın ÇB; Tansuyu M; Cesur Z; Naesens L; Göktaş F
    Bioorg Chem; 2021 Jul; 112():104958. PubMed ID: 33979734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Innovative Folate Inhibitors Leveraging the Amino Dihydrotriazine Motif from Cycloguanil for Their Potential as Anti-
    Francesconi V; Rizzo M; Pozzi C; Tagliazucchi L; Konchie Simo CU; Saporito G; Landi G; Mangani S; Carbone A; Schenone S; Santarém N; Tavares J; Cordeiro-da-Silva A; Costi MP; Tonelli M
    ACS Infect Dis; 2024 Aug; 10(8):2755-2774. PubMed ID: 38953453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D-QSAR Study on dihydro-1,3,5-triazines and their spiro derivatives as DHFR inhibitors by comparative molecular field analysis (CoMFA).
    Ma X; Xiang G; Yap CW; Chui WK
    Bioorg Med Chem Lett; 2012 May; 22(9):3194-7. PubMed ID: 22483391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,3,5-triazaspiro[5.5]undeca-2,4-dienes as selective Mycobacterium tuberculosis dihydrofolate reductase inhibitors with potent whole cell activity.
    Yang X; Wedajo W; Yamada Y; Dahlroth SL; Neo JJ; Dick T; Chui WK
    Eur J Med Chem; 2018 Jan; 144():262-276. PubMed ID: 29274493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico ADMET study, docking, synthesis and antimalarial evaluation of thiazole-1,3,5-triazine derivatives as Pf-DHFR inhibitor.
    Sahu S; Ghosh SK; Gahtori P; Pratap Singh U; Bhattacharyya DR; Bhat HR
    Pharmacol Rep; 2019 Oct; 71(5):762-767. PubMed ID: 31351317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro biological evaluation of biguanides and dihydrotriazines against Brugia malayi and folate reversal studies.
    Bag S; Tawari NR; Sharma R; Goswami K; Reddy MV; Degani MS
    Acta Trop; 2010 Jan; 113(1):48-51. PubMed ID: 19769933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the ability of dihydropyrimidine-5-carboxamide and 5-benzyl-2,4-diaminopyrimidine-based analogues for the selective inhibition of L. major dihydrofolate reductase.
    Bibi M; Qureshi NA; Sadiq A; Farooq U; Hassan A; Shaheen N; Asghar I; Umer D; Ullah A; Khan FA; Salman M; Bibi A; Rashid U
    Eur J Med Chem; 2021 Jan; 210():112986. PubMed ID: 33187806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and antifolate activity of new analogues of piritrexim and other diaminopyrimidine dihydrofolate reductase inhibitors with omega-carboxyalkoxy or omega-carboxy-1-alkynyl substitution in the side chain.
    Chan DC; Fu H; Forsch RA; Queener SF; Rosowsky A
    J Med Chem; 2005 Jun; 48(13):4420-31. PubMed ID: 15974594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of biguanide and dihydrotriazine derivatives as potential inhibitors of dihydrofolate reductase of opportunistic microorganisms.
    Bag S; Tawari NR; Queener SF; Degani MS
    J Enzyme Inhib Med Chem; 2010 Jun; 25(3):331-9. PubMed ID: 19874136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2,4-diamino-5-deaza-6-substituted pyrido[2,3-d]pyrimidine antifolates as potent and selective nonclassical inhibitors of dihydrofolate reductases.
    Gangjee A; Vasudevan A; Queener SF; Kisliuk RL
    J Med Chem; 1996 Mar; 39(7):1438-46. PubMed ID: 8691474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.